Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Oct 2;20(5):1019–1028.e3. doi: 10.1016/j.cgh.2021.09.029

Table 1.

Demographic and Baseline Clinical Characteristics

Group
Characteristic Control (n=24) FD (n=40) P Value
Age, y 40 (13) 42 (13) .7
Body mass index, kg/m2 26.1 (4.7) 26.7 (6.6) .9
Women 14 (58) 31 (78) .2
Mean (SD) NDI dyspepsia symptom severity score a 12.95 (12.5-13.0) 10.8 (10.03-11.41) <.001
Mean (SD) NDI QOL score b 100 (100-100) 41.3 (18.6-62.1) <.001
PAGI-SYM subscores, Median (IQR) c
 Heartburn 0 (0-0.14) 1.86 (1.14-2.55) <.001
 Nausea, vomiting, and regurgitation 0 (0-0) 1 (0.33-2.33) <.001
 Early satiety 0 (0-0.25) 3.1 (2.5-4.0) <.001
 Bloating 0 (0-0.13) 3.5 (2.5-4.63) <.001
 Upper abdominal pain 0 (0-0) 3.5 (2.38-4.0) <.001
Anxiety, n d
 Borderline 0 7 .04
 Definite 0 11 .005
Depression, n
 Borderline 0 8 .02
 Definite 0 3 .3
Mean (SD) GE thalf for solids, min 103.8 (32.5) 122.6 (35.0) .02
Mean (SD) GE thalf for liquids, min 16 (5) 22 (10) .004
Colonic filling at 6 hours, % 56 (21) 40(18) .004

GE, gastric emptying; NDI, Nepean Dyspepsia Index; FD, nonulcer dyspepsia; PAGI-SYM, Patient Assessment of Upper Gastrointestinal Disorders-Symptom Severity; QOL, quality of life.

a

Least and most severe symptoms are 13 and 0

b

Best and worst QOL are 100 and 0

c

Least and most severe symptoms are respectively 0 and 5

d

Borderline and definite anxiety (or depression) are 8-10 and 11-21